Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.

Learn how to tell if your business could be facing a cash crunch—and what to do about it Written By Written by Staff Senior Editor, Buy Side Miranda Marquit is a staff senior personal finance editor ...

Forbes contributors publish independent expert analyses and insights. Dr. Tracy Brower writes about joy, community and the future of work. This voice experience is generated by AI. Learn more. This ...

NEW YORK, NY, UNITED STATES, January 6, 2026 /EINPresswire.com/ — Panther Life Sciences announces expanded access to its high-precision Microarray Patch (MAP) platform for pharmaceutical and ...

ChatGPT is a lot simpler to use than you think, and there are many ways to make it work well for you. Amanda Smith is a freelance journalist and writer. She reports on culture, society, human interest ...

Stripe is a payment service provider that accepts credit cards, digital wallets and many other payment methods. Many, or all, of the products featured on this page are from our advertising partners ...

Zepbound works by mimicking the action of two hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). GIP and GLP-1 activate certain receptors (binding sites) ...

During a recent workshop, a senior executive said to me, “None of us knows how people will learn in this new era.” Lynda Gratton is a professor of management practice at London Business School and the ...

Cost basis is the original purchase price of an asset. Tracking cost basis is key to tax-efficient investing. Many, or all, of the products featured on this page are from our advertising partners who ...

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

BATON ROUGE — At the start of the new year, the college football transfer portal will open. Players who intend to leave their current team and find a new home will officially be able to enter their ...

BRISBANE, Australia and CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive ...